Researchers create a healthier form of starch in the cassava plant

Researchers at the RIKEN Center for Sustainable Resource Science (CSRS) in Japan have recently created a healthier form of starch in the cassava plant. Published in the scientific journal Plant Molecular Biology, the study shows how reducing levels of starch branching enzymes (SBEs) in cassava plants changes the composition of tapioca starch, making it more resistant to digestion and healthier for us to eat.

Most of the starch we eat comes from cereal crops like rice, corn, and wheat or tuber crops like potato and cassava. Starch contains two molecules-;amylose and amylopectin. The difference between them is that amylose is a straight chain of glucose molecules connected end to end, while in amylopectin the chains branch out like a tree.

The crops we eat differ in their relative amounts of amylose and amylopectin. For example, rice starch contains about 35% amylose (65% amylopectin), while cassava starch, commonly called tapioca, contains only about 17% amylose (82% amylopectin). Normal starch that includes branching amylopectin is easily digested by enzymes in saliva.

That sounds good, but actually amylose and less-branched amylopectin are healthier because their structures can resist digestion. Instead of giving us unhealthy blood sugar spikes, resistant starch travels to our gut where it becomes food for all the good bacteria that live there and keep us healthy.

The RIKEN CSRS team focused on the cassava plant because it is often overlooked, even though it is one of most import crops in tropical and subtropical regions. "By suppressing multiple genes one by one, we were able to increase the amount of resistant tapioca by about 63%." says lead researcher Yoshinori Utsumi. "Not only will this starch improve intestinal function, but it will also improve blood sugar and insulin responsiveness."

Resistant starch has two characteristics. The first is amylopectin with fewer branches and longer chains, making is harder to digest. The second is a lower percentage of amylopectin overall. To generate resistant starch, the researchers focused on the enzyme that helps create the branches in amylopectin. To create a branch, one chain of amylose must attach to the middle of another chain of amylose. Creating this bond requires starch branching enzymes (SBEs).

The team reasoned that reducing this enzyme's activity would be a way to generate resistant starch. Therefore, the first step was to identify the SBE genes in the cassava genome. Analysis revealed three SBE genes, with a few subtypes. SBE1 and SBE2a appear to be involved in making amylopectin in cassava leaves and roots, while SBE2c is only in the roots.

Next, the researchers created several lines of transgenic cassava to compare with unmodified wildtype cassava. The most successful transgenic lines were those in which both SBE1 and SBE2 expression were reduced to about 10% of wildtype expression. Looking at the factors that increase starch resistance, the researchers found that although wildtype cassava contained about 17% amylose, the roots of two transgenic lines in which both SBE1 and SBE2 were reduced contained about 40% amylose.

These lines also produced root amylopectin with fewer branches and longer chains. Overall, the percent of resistant tapioca starch rose from 0.4% to about 25%, a whopping increase of about 6300%, although the total amount of starch did decrease a little.

In addition to advancing cassava molecular breeding, we hope that our findings will lead to more functional foods that improve human health. Now that we have identified the cassava genes for molecularly more resistant starch, the next step will be to verify the effectiveness of these plants and the tapioca starch they produce."

Yoshinori Utsumi, Study Lead Researcher, RIKEN

Journal reference:

Utsumi, Y., et al. (2021) Suppressed expression of starch branching enzyme 1 and 2 increases resistant starch and amylose content and modifies amylopectin structure in cassava. Plant Molecular Biology.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of AZoLifeSciences.
Post a new comment
You might also like...
Black death and the development of immune genes